[1]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.1371-1375
[2]JournalofMedicinalChemistry,2019,vol.62,p.2428-2446
[3]OrganicLetters,2019,vol.21,p.5111-5115
[4]BioorganicandMedicinalChemistry,2014,vol.22,p.1909-1915
[5]BioorganicandMedicinalChemistry,1996,vol.4,p.1203-1207
[6]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.2724-2729
[7]Molecules,2021,vol.26
[1]Chapoulaud,V.Gautheron;Salliot;Ple;Turck;Queguiner[Tetrahedron,1999,vol.55,#17,p.5389-5404]
[1]Chapoulaud,V.Gautheron;Salliot;Ple;Turck;Queguiner[Tetrahedron,1999,vol.55,#17,p.5389-5404]
[1]Gazit,Aviv;Chen,Jeffrey;Harald,App;McMahon,Gerald;Hirth,Peter;Chen,Irit;Levitzki,Alexander[BioorganicandMedicinalChemistry,1996,vol.4,#8,p.1203-1207]
[2]Bensinger,Dennis;Stubba,Daniel;Cremer,Anjali;Kohl,Vanessa;Waßmer,Theresa;Stuckert,Johanna;Engemann,Victoria;Stegmaier,Kimberly;Schmitz,Katja;Schmidt,Boris[JournalofMedicinalChemistry,2019,vol.62,#5,p.2428-2446]
Title: Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.
Journal: Journal of medicinal chemistry 20120209
Title: Investigation of a novel molecular descriptor for the lead optimization of 4-aminoquinazolines as vascular endothelial growth factor receptor-2 inhibitors: application for quantitative structure-activity relationship analysis in lead optimization.
Journal: Bioorganic & medicinal chemistry letters 20110301
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor.
Journal: Journal of medicinal chemistry 19960105
Title: Sudbeck EA, et al. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res. 1999 Jun;5(6):1569-82.
Title: Tibbles HE, et al. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J Biol Chem. 2001 May 25;276(21):17815-22.
